REPORT ID 13769

United States Veterinary Therapeutics Market Report 2017

Publish Date
22-Nov-17
Pages
95
Format
Electronic (PDF)

In this report, the United States Veterinary Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Veterinary Therapeutics in these regions, from 2012 to 2022 (forecast).

United States Veterinary Therapeutics market competition by top manufacturers/players, with Veterinary Therapeutics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Bayer AG
    Boehringer Ingelheim GmbH
    Ceva Sante Animale
    Dechra Pharmaceuticals PLC
    Eli Lilly and Company (Elanco Animal Health)
    Merck Animal Health
    Sanofi (Merial Animal Health)
    Virbac
    Vetoquinol S.A.
    Zoetis, Inc.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    By Drugs
        Anti-inflammatory
        Parasiticides
        Other
    By Vaccines
        Inactivated Vaccines
        Live Attenuated Vaccines
        Recombinant Vaccines
    By Medicated Feed Additives
        Amino Acids
        Antibiotics
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospitals
    Veterinary Clinics
    Drug Stores

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Veterinary Therapeutics Market Report 2017
1 Veterinary Therapeutics Overview
    1.1 Product Overview and Scope of Veterinary Therapeutics
    1.2 Classification of Veterinary Therapeutics by Product Category
        1.2.1 United States Veterinary Therapeutics Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Veterinary Therapeutics Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Anti-inflammatory
        1.2.4 Parasiticides
        1.2.5 Other
    1.3 United States Veterinary Therapeutics Market by Application/End Users
        1.3.1 United States Veterinary Therapeutics Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Hospitals
        1.3.3 Veterinary Clinics
        1.3.4 Drug Stores
    1.4 United States Veterinary Therapeutics Market by Region
        1.4.1 United States Veterinary Therapeutics Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Veterinary Therapeutics Status and Prospect (2012-2022)
        1.4.3 Southwest Veterinary Therapeutics Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Veterinary Therapeutics Status and Prospect (2012-2022)
        1.4.5 New England Veterinary Therapeutics Status and Prospect (2012-2022)
        1.4.6 The South Veterinary Therapeutics Status and Prospect (2012-2022)
        1.4.7 The Midwest Veterinary Therapeutics Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Veterinary Therapeutics (2012-2022)
        1.5.1 United States Veterinary Therapeutics Sales and Growth Rate (2012-2022)
        1.5.2 United States Veterinary Therapeutics Revenue and Growth Rate (2012-2022)

2 United States Veterinary Therapeutics Market Competition by Players/Suppliers
    2.1 United States Veterinary Therapeutics Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Veterinary Therapeutics Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Veterinary Therapeutics Average Price by Players/Suppliers (2012-2017)
    2.4 United States Veterinary Therapeutics Market Competitive Situation and Trends
        2.4.1 United States Veterinary Therapeutics Market Concentration Rate
        2.4.2 United States Veterinary Therapeutics Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Veterinary Therapeutics Manufacturing Base Distribution, Sales Area, Product Type

3 United States Veterinary Therapeutics Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Veterinary Therapeutics Sales and Market Share by Region (2012-2017)
    3.2 United States Veterinary Therapeutics Revenue and Market Share by Region (2012-2017)
    3.3 United States Veterinary Therapeutics Price by Region (2012-2017)

4 United States Veterinary Therapeutics Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Veterinary Therapeutics Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Veterinary Therapeutics Revenue and Market Share by Type (2012-2017)
    4.3 United States Veterinary Therapeutics Price by Type (2012-2017)
    4.4 United States Veterinary Therapeutics Sales Growth Rate by Type (2012-2017)

5 United States Veterinary Therapeutics Sales (Volume) by Application (2012-2017)
    5.1 United States Veterinary Therapeutics Sales and Market Share by Application (2012-2017)
    5.2 United States Veterinary Therapeutics Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Veterinary Therapeutics Players/Suppliers Profiles and Sales Data
    6.1 Bayer AG
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Veterinary Therapeutics Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Bayer AG Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Boehringer Ingelheim GmbH
        6.2.2 Veterinary Therapeutics Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Boehringer Ingelheim GmbH Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Ceva Sante Animale
        6.3.2 Veterinary Therapeutics Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Ceva Sante Animale Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Dechra Pharmaceuticals PLC
        6.4.2 Veterinary Therapeutics Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Dechra Pharmaceuticals PLC Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Eli Lilly and Company (Elanco Animal Health)
        6.5.2 Veterinary Therapeutics Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Merck Animal Health
        6.6.2 Veterinary Therapeutics Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Merck Animal Health Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Sanofi (Merial Animal Health)
        6.7.2 Veterinary Therapeutics Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Sanofi (Merial Animal Health) Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Virbac
        6.8.2 Veterinary Therapeutics Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Virbac Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Vetoquinol S.A.
        6.9.2 Veterinary Therapeutics Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Vetoquinol S.A. Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Zoetis, Inc.
        6.10.2 Veterinary Therapeutics Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Zoetis, Inc. Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview

7 Veterinary Therapeutics Manufacturing Cost Analysis
    7.1 Veterinary Therapeutics Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Veterinary Therapeutics

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Veterinary Therapeutics Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Veterinary Therapeutics Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Veterinary Therapeutics Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Veterinary Therapeutics Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Veterinary Therapeutics Sales Volume Forecast by Type (2017-2022)
    11.3 United States Veterinary Therapeutics Sales Volume Forecast by Application (2017-2022)
    11.4 United States Veterinary Therapeutics Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer